ArticleLupus science & medicine2026
Identification and functional characterisation of SCO1 as a mitochondria-related biomarker in lupus nephritis.
Article in Lupus science & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLupus nephritis (LN) is a severe complication of systemic lupus erythematosus. Mitochondrial dysfunction and inflammation are key contributors to its pathogenesis, yet the underlying mechanisms remain incompletely understood and reliable biomarkers are limited. This study investigates mitochondrial-related genes (MRGs) in LN and evaluates their potential as biomarkers.
methodsDifferentially expressed genes (DEGs) were obtained from the Gene Expression Omnibus database and MRGs were derived from the MitoCarta3.0 dataset. Weighted gene co-expression network analysis identified key modules, followed by Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes enrichment analyses of mitochondrial DEGs (MitoDEGs). Protein-protein interaction network analysis and random forest modelling were applied to identify hub MitoDEGs. Their diagnostic performance was evaluated using receiver operating characteristic curves. Immune cell infiltration was estimated using single-sample gene set enrichment analysis and correlations with hub MitoDEGs were analysed. Immunofluorescence staining and functional assays in HK-2 cells were performed to validate the expression and biological roles of the hub genes.
resultsAmong the 36 MitoDEGs, synthesis of cytochrome c oxidase 1 (SCO1) was identified. SCO1 exhibited strong discriminatory power in both the training and validation sets. After false discovery rate correction, SCO1 showed significant positive correlations with CD8+T cells, naive CD4+T cells and resting memory CD4+T cells. Immunofluorescence staining confirmed that SCO1 was predominantly expressed in renal tubules and was significantly upregulated in patients with LN compared with healthy controls. Functional validation demonstrated that SCO1 overexpression enhanced cell viability, whereas its knockdown reduced cell viability, increased mitochondrial reactive oxygen apecies and decreased mitochondrial membrane potential, without affecting ATP levels. SCO1 modulation altered P62 expression but did not significantly affect PARKIN, PINK1, or LC3B levels.
conclusionSCO1 showed elevated expression in renal tubules and strong discriminatory ability. It may help preserve tubular cell viability and mitochondrial homeostasis under inflammatory stress, highlighting its potential as a diagnostic biomarker and a candidate for further mechanistic investigation in LN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.